Diabetes drug helps repair UV-damaged DNA in cells of 'Moon children'

November 20, 2017, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Visualization of the DNA repair proteins XPC (in green) and MUTYH (in red) to sites of UV-induced DNA damage within the nucleus (in blue), within a human cell. Credit: CeMM/ Abdelghani Mazouzi

The severe and debilitating genetic disease Xeroderma pigmentosum impedes cells to repair UV-induced DNA damage. Scientists from CeMM found a drug approved for diabetes treatment to alleviate the impact of the gene defect in cell culture, which led to the discovery of a previously unknown DNA repair mechanism. The study was published in Molecular Cell.

The destructive force of UV radiation on DNA molecules is only fully visible, when repair mechanisms fail: patients with the rare genetic disease Xeroderma pigmentosum - also known as "Moon children' - develop inflammations upon exposure to only small amounts of sunlight, rough-surfaced growths and eventually skin cancer occurs often in early age. The severe condition is caused by mutations in the genes for the (NER) pathway - the only known mechanism that deals with UV-induced DNA damage in human cells. Although first described in 1874, Xeroderma pigmentosum to date lacks any curative treatment.

Led by Joanna Loizou, Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, and together with collaborators from the Medical University of Vienna and the IRB Barcelona, the scientists at CeMM found in their most recent publication that the FDA-approved diabetes drug acetohexamide significantly improves the resilience of NER deficient cells against UV radiation in vitro. Above that, the study published in Molecular Cell identified the responsible molecular mode of action - a hitherto unknown, NER-independent repair mechanism for UV-induced DNA damage. The study has not tested the use of acetohexamide in Xeroderma pigmentosum patients.

For their study, the scientists of Loizou's team developed a special chemical screening approach for compounds that would allow Xeroderma pigmentosum-disease cells to survival UV treatment better. Using the CLOUD (Cemm Library of Unique Drugs), this approach led to the identification of acetohexamide: By treating Xeroderma pigmentosum-disease cells with the diabetes drug, these cells could now repair UV-induced DNA damage more efficiently. A multitude of subsequent experiments eventually led to the elucidation of the underlying molecular mechanism: acetohexamide leads to the degradation of the DNA repair enzyme MUTYH, triggering an hitherto unknown NER-independent mechanism for removing UV-induced DNA damage.

"MUTYH has not been previously implicated in the removal of UV-induced lesions," emphazises Abdelghani Mazouzi, first author of the study. "However, our data collectively show that the anti-diabetic drug acetohexamide can alleviate the sensitivity of NER-deficient cells and enhance the repair of UV lesions through the degradation of MUTYH." "Loss of MUTYH allows Xeroderma pigmentosum-disease to deal with UV-induced DNA damage more proficiently" Joanna Loizou summarizes. "Those findings are not only a valuable contribution to the fundamental, molecular understanding of DNA , but could also pave the way for a novel therapeutic approach for this severe and debilitating disease, for which there is no ".

Explore further: Targeting PTEN may prevent skin cancer

More information: Abdelghani Mazouzi et al, Repair of UV-Induced DNA Damage Independent of Nucleotide Excision Repair Is Masked by MUTYH, Molecular Cell (2017). DOI: 10.1016/j.molcel.2017.10.021

Related Stories

Targeting PTEN may prevent skin cancer

July 26, 2011

Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from UVB radiation, a known risk factor for non-melanoma skin cancer, according to a study published in Cancer ...

Chaperone enzyme provides new target for cancer treatments

January 18, 2011

UNC scientists who study how cells repair damage from environmental factors like sunlight and cigarette smoke have discovered how a "chaperone" enzyme plays a key role in cells' ability to tolerate the DNA damage that leads ...

DNA and its complexes

April 13, 2010

Throughout life, DNA repair mechanisms go to work during exposure (UV radiation, etc.) in order to protect the human genetic code. This role is assured by the NER complex.

Scientists identify how repair protein finds DNA damage

October 6, 2016

Researchers at the University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute (UPCI) have demonstrated how Rad4, a protein involved in DNA repair, scans the DNA in a unique pattern of movement ...

Recommended for you

How do horses read human emotional cues?

June 21, 2018

Scientists have demonstrated for the first time that horses integrate human facial expressions and voice tones to perceive human emotion, regardless of whether the person is familiar or not.

Fish's use of electricity might shed light on human illnesses

June 21, 2018

Deep in the night in muddy African rivers, a fish uses electrical charges to sense the world around it and communicate with other members of its species. Signaling in electrical spurts that last only a few tenths of a thousandth ...

Not junk: 'Jumping gene' is critical for early embryo

June 21, 2018

A so-called "jumping gene" that researchers long considered either genetic junk or a pernicious parasite is actually a critical regulator of the first stages of embryonic development, according to a new study in mice led ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.